Page not found

Search results

  1. Tech Connect, Vol. 6, Issue 7: Collaboration seeks to develop new therapies for bone and other diseases

    ... Manager of Biotech Licensing in the  Vanderbilt Center for Technology Transfer & Commercialization , facilitated the agreement with La ...  Anti-factor XI monoclonal antibodies and methods of use thereof ...

    steelmk - 11/15/2016 - 4:11pm

  2. FIRST Diagnostics wins 2015 Tech Venture Challenge

    ... then develop commercialization plans for the researcher's technology and present the plans before a panel of judges. Four business plans ... agent has high potential for translation to clinical use as a cancer diagnostic for improved tumor detection in humans. ...

    nbmas - 10/02/2015 - 10:43am

  3. Tech Connect, Vol. 6, Issue 12: nPhase closes on its first round of funding

    ... quickly and securely, and is currently in production use or development build-status for more than 217,000 projects with ... Held a call with an agriculture and animal health technology development group to discuss the insect repellent compounds created ...

    steelmk - 11/15/2016 - 2:58pm

  4. Tech Connect, Vol. 6, Issue 22: CTTC team presents, participates at 2016 SEMDA meeting

    ... Association (SEMDA) annual meeting as part of CTTC’s technology marketing efforts. This year, twelve Vanderbilt technologies were ... In the interview, Vito Quaranta describes how use of automated microscopes can be used to improve early drug discovery, ...

    steelmk - 11/10/2016 - 7:45am

  5. Innovation Catalyst Fund

    ... colleges, with management provided through the Center for Technology Transfer and Commercialization.      Key Features ... distributed based on milestone completion   Use of Funds The Innovation Catalyst Fund project selection will be ...

    cttc_admin - 04/24/2024 - 7:21am

  6. Cellular engines of wound repair have distinct roles

    ... population of cells working in the same manner to coordinate wound repair,” said  Pampee Young , MD, PhD, adjunct professor of ... without impairing the functions that are necessary for wound healing. Young, who is the  Chief Medical Officer  of the American Red ...

    sommers - 08/14/2019 - 8:32am

  7. Discovery Vanderbilt invests in three faculty-initiated startups: HeroWear, IDBiologics and Virtuoso

    ... the  Center for Rehabilitation Engineering and Assistive Technology  by  Karl Zelik , associate professor of mechanical ... and commercialization by HeroWear and for field use by the Army. This month, HeroWear introduced its newest commercially ... as Virtuoso chief executive officer, and Webster is chief technology officer. School of Engineering alum Richard Hendrick, PhD’17, is ...

    sommers - 05/23/2023 - 12:14pm

  8. Herowear exosuit technology launches with on-campus departments

    ... of the  Center for Rehabilitation Engineering & Assistive Technology  lab.  In late March 2023, the  Division of Administration ...  and  Mail Services . The pilot test includes the use of 27 Apex 1 suits over six weeks. During the pilot test, users will wear ...

    sommers - 04/23/2023 - 12:47pm

  9. One Vanderbilt technology earns patent protection in April

    ... Inventors 11,633,370 Use of Scavengers of Reactive Gamma-Ketoaldehydes to Extend Cell Lifespan and ...

    sommers - 04/27/2023 - 9:30am

  10. Theralink® Acquires Exclusive Landmark Immunotherapy Patent including Biomarker from Vanderbilt University

    ... with the ultimate goal of aiding precision medicine in the use of immunotherapy in breast cancer and other tumor types. Migrating this ... and protein biomarker platform and LDTs, Theralink’s technology targets multiple areas of oncology and drug development. In addition ...

    sommers - 04/24/2023 - 1:45pm